LUDWIG ENTERPRISES, INC.
Company Information
Industry
Services-Medical Laboratories
SIC Code
8071
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
NV
Business Address
3160 NW 1 AVENUE, POMPANO BEACH, FL, 33064
Mailing Address
3160 NW 1 AVENUE, POMPANO BEACH, FL, 33064
Phone
786-235-9026
Fiscal Year End
1231
EIN
611133438
Financial Overview
FY2025 FY
$217
Revenue
$4.64M
Total Liabilities
-$2.38M
Stockholders' Equity
$217
Cash & Equivalents
$-0.01
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1/A IPO registration amendment | April 2, 2026 | View on SEC |
| 10-K Annual financial report | March 16, 2026 | View on SEC |
| S-1/A IPO registration amendment | February 12, 2026 | View on SEC |
| 8-K Current report of material events | February 11, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| S-1/A IPO registration amendment | October 14, 2025 | View on SEC |
| 8-K Current report of material events | October 1, 2025 | View on SEC |
| 8-K Current report of material events | September 8, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 12, 2025 | View on SEC |
| 8-K Current report of material events | July 30, 2025 | View on SEC |
Annual Reports
10-K
March 16, 2026
- Pioneering mRNA-based screening tests for chronic diseases like cancer.
- Flagship Revealia™ Breast test is a non-invasive cheek swab for early detection.
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.